Celebrate Mom with a Health Check: DHR Health’s “Mammos for Moms” Mammogram Screening Special

Translate to Spanish or other 102 languages!

In support of women’s health and early detection, DHR Health is delighted to offer the "Mammos for Moms" screening special from now until June 30, 2026. This screening mammogram will provide digital 3D (three dimensional) tomography imaging and radiologist interpretation for only $99. A referral from a physician or other health care provider is required. Courtesy image
In support of women’s health and early detection, DHR Health is delighted to offer the “Mammos for Moms” screening special from now until June 30, 2026. This screening mammogram will provide digital 3D (three dimensional) tomography imaging and radiologist interpretation for only $99. A referral from a physician or other health care provider is required. Courtesy image
- Advertisement -

In support of women’s health and early detection, DHR Health is delighted to offer the “Mammos for Moms” screening special from now until June 30, 2026. This screening mammogram will provide digital 3D (three dimensional) tomography imaging and radiologist interpretation for only $99. A referral from a physician or other health care provider is required.

Breast cancer is a significant health concern in our society, affecting women in the Rio Grande Valley and worldwide. Early detection is crucial for successful treatment, and mammograms play a vital role in identifying breast abnormalities even before physical symptoms appear.

Mammogram guidelines typically advise women with an average risk of breast cancer to start screening at age 40 and continue annually thereafter, according to the National Comprehensive Cancer Network (NCCN). However, screening recommendations may begin earlier depending on individual risk factors, such as family history or genetic predispositions. Screening frequency is annual for those at average risk and stop around age 80. Ultimately, screening decisions are tailored to each woman’s unique circumstances, so it’s crucial to begin breast health discussions with a healthcare provider to determine if screening earlier than 40 is necessary.

- Advertisement -

“Routine mammograms enable early detection of breast abnormalities and support individualized risk assessment, helping to guide appropriate follow-up care and preventive measures,” said Dr. Lisa Chapa, DHR Health Breast Surgical Oncologist. “By prioritizing mammograms and screenings, individuals empower themselves with knowledge and proactive steps toward maintaining breast health and overall well-being.”

The mammogram screening special is being offered at several DHR Health locations in Edinburg, McAllen, Weslaco, and Brownsville. The location addresses are: Women’s Imaging Center at Dove located inside the DHR Health Medical Building at 1100 E. Dove, DHR Health Women’s Imaging Center at Lindberg located at 300 Lindberg in McAllen, DHR Health Imaging Center at Mid Valley located at 1121 James Street in Weslaco, and the DHR Health Brownsville Radiology Department located at 4750 North Expressway in Brownsville. To make an appointment at any of these locations, please call (956) 362-7503.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Children’s Shares Halloween Safety Tips

Halloween may be known for its tricks and treats, but amid the excitement of the holiday, potential hazards can quickly turn a night of fun into an unexpected trip to the emergency room.

DHR Health Brownsville’s 2nd Annual Fall Fest and Health Fair, Oct. 24th

DHR Health Brownsville is bringing families together for a day of wellness and fun at its 2nd Annual Fall Fest and Health Fair. The event will be held from 8 a.m. to noon on October 24, 2026, at the DHR Health Brownsville Hospital, at 4750 North Expressway 77, in north Brownsville. The event is free and open to the public.

The Impact of Physical Activity on Parkinson’s Decline

For 68-year-old Robert Kennedy, a retired Florida Power and Light foreman, the secret to managing his Parkinson symptoms is movement.

FDA Approves First-of-Its-Kind Chronic Hepatitis B Treatment 

The U.S. Food and Drug Administration approved Hibsago (bepirovirsen) injection, in combination with existing antiviral therapy, to treat chronic hepatitis B virus (HBV) infection in certain adults without cirrhosis.
- Advertisement -